Literature DB >> 22379068

Prospective comparison of prognostic scores in palliative care cancer populations.

Marco Maltoni1, Emanuela Scarpi, Cristina Pittureri, Francesca Martini, Luigi Montanari, Elena Amaducci, Stefania Derni, Laura Fabbri, Marta Rosati, Dino Amadori, Oriana Nanni.   

Abstract

PURPOSE: Predicting prognosis in advanced cancer aids physicians in clinical decision making and can help patients and their families to prepare for the time ahead.
MATERIALS AND METHODS: This multicenter, observational, prospective, nonrandomized population-based study evaluated life span prediction of four prognostic scores used in palliative care: the original palliative prognostic score (PaP Score), a variant of PaP Score including delirium (D-PaP Score), the Palliative Performance Scale, and the Palliative Prognostic Index.
RESULTS: A total of 549 patients were enrolled onto the study. Median survival of the entire group was 22 days (95% confidence intervals [95% CI] = 19-24). All four prognostic models discriminated well between groups of patients with different survival probabilities. Log-rank tests were all highly significant (p < .0001). The PaP and D-PaP scores were the most accurate, with a C index of 0.72 (95% CI = 0.70-0.73) and 0.73 (95% CI = 0.71-0.74), respectively.
CONCLUSION: It can be confirmed that all four prognostic scores used in palliative care studies accurately identify classes of patients with different survival probabilities. The PaP Score has been extensively validated and shows high accuracy and reproducibility in different settings.

Entities:  

Mesh:

Year:  2012        PMID: 22379068      PMCID: PMC3316931          DOI: 10.1634/theoncologist.2011-0397

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  65 in total

1.  Validation, calibration, revision and combination of prognostic survival models.

Authors:  H C van Houwelingen
Journal:  Stat Med       Date:  2000-12-30       Impact factor: 2.373

2.  Impact of delirium on the short term prognosis of advanced cancer patients. Italian Multicenter Study Group on Palliative Care.

Authors:  A Caraceni; O Nanni; M Maltoni; L Piva; M Indelli; E Arnoldi; M Monti; L Montanari; D Amadori; F De Conno
Journal:  Cancer       Date:  2000-09-01       Impact factor: 6.860

3.  Validation of the palliative performance scale for inpatients admitted to a palliative care unit in Sydney, Australia.

Authors:  Kiran Virik; Paul Glare
Journal:  J Pain Symptom Manage       Date:  2002-06       Impact factor: 3.612

Review 4.  Prognostic factors in advanced cancer patients: evidence-based clinical recommendations--a study by the Steering Committee of the European Association for Palliative Care.

Authors:  Marco Maltoni; Augusto Caraceni; Cinzia Brunelli; Bert Broeckaert; Nicholas Christakis; Steffen Eychmueller; Paul Glare; Maria Nabal; Antonio Viganò; Philip Larkin; Franco De Conno; Geoffrey Hanks; Stein Kaasa
Journal:  J Clin Oncol       Date:  2005-09-01       Impact factor: 44.544

5.  Prognostic disclosure to patients with cancer near the end of life.

Authors:  E B Lamont; N A Christakis
Journal:  Ann Intern Med       Date:  2001-06-19       Impact factor: 25.391

6.  Development of terminal cancer prognostic score as an index in terminally ill cancer patients.

Authors:  Y H Yun; D S Heo; B Y Heo; T W Yoo; J M Bae; S H Ahn
Journal:  Oncol Rep       Date:  2001 Jul-Aug       Impact factor: 3.906

7.  Independent prospective validation of the PaP score in terminally ill patients referred to a hospital-based palliative medicine consultation service.

Authors:  P Glare; K Virik
Journal:  J Pain Symptom Manage       Date:  2001-11       Impact factor: 3.612

8.  Improved accuracy of physicians' survival prediction for terminally ill cancer patients using the Palliative Prognostic Index.

Authors:  T Morita; J Tsunoda; S Inoue; S Chihara
Journal:  Palliat Med       Date:  2001-09       Impact factor: 4.762

9.  Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study.

Authors:  N A Christakis; E B Lamont
Journal:  BMJ       Date:  2000-02-19

Review 10.  Survival prediction in terminal cancer patients: a systematic review of the medical literature.

Authors:  A Viganò; M Dorgan; J Buckingham; E Bruera; M E Suarez-Almazor
Journal:  Palliat Med       Date:  2000-09       Impact factor: 4.762

View more
  31 in total

1.  A scoring system to guide the decision for a new systemic treatment after at least two lines of palliative chemotherapy for metastatic cancers: a prospective study.

Authors:  Brice Chanez; François Bertucci; Marine Gilabert; Anne Madroszyk; Frédérique Rousseau; Delphine Perrot; Patrice Viens; Jean-Luc Raoul
Journal:  Support Care Cancer       Date:  2017-03-28       Impact factor: 3.603

2.  Development and validation of a prognostic scale for hospitalized patients with terminally ill cancer in China.

Authors:  Yu Huang; Qingsong Xi; Shu Xia; Xushi Wang; Yong Liu; Chao Huang; Wei Zheng; Shiying Yu
Journal:  Support Care Cancer       Date:  2013-09-07       Impact factor: 3.603

3.  Magnitude of score change for the palliative prognostic index for survival prediction in patients with poor prognostic terminal cancer.

Authors:  Chia-Yen Hung; Hung-Ming Wang; Chen-Yi Kao; Yung-Chang Lin; Jen-Shi Chen; Yu-Shin Hung; Wen-Chi Chou
Journal:  Support Care Cancer       Date:  2014-05-06       Impact factor: 3.603

Review 4.  Dealing with prognostic uncertainty: the role of prognostic models and websites for patients with advanced cancer.

Authors:  David Hui; John P Maxwell; Carlos Eduardo Paiva
Journal:  Curr Opin Support Palliat Care       Date:  2019-12       Impact factor: 2.302

5.  Interleukin-6 but not tumour necrosis factor-alpha predicts survival in patients with advanced cancer.

Authors:  Sang-Yeon Suh; Youn Seon Choi; Chang Hwan Yeom; Sang Mi Kwak; Ho Min Yoon; Dae Gyun Kim; Su-Jin Koh; Jeanno Park; Myung Ah Lee; Yong Joo Lee; Ah-Ram Seo; Hong-Yup Ahn; Eunji Yim
Journal:  Support Care Cancer       Date:  2013-07-05       Impact factor: 3.603

6.  Surprise Questions for Survival Prediction in Patients With Advanced Cancer: A Multicenter Prospective Cohort Study.

Authors:  Jun Hamano; Tatsuya Morita; Satoshi Inoue; Masayuki Ikenaga; Yoshihisa Matsumoto; Ryuichi Sekine; Takashi Yamaguchi; Takeshi Hirohashi; Tsukasa Tajima; Ryohei Tatara; Hiroaki Watanabe; Hiroyuki Otani; Chizuko Takigawa; Yoshinobu Matsuda; Hiroka Nagaoka; Masanori Mori; Naoki Yamamoto; Mie Shimizu; Takeshi Sasara; Hiroya Kinoshita
Journal:  Oncologist       Date:  2015-06-08

7.  Using the Palliative Performance Scale to Estimate Survival for Patients at the End of Life: A Systematic Review of the Literature.

Authors:  Dawon Baik; David Russell; Lizeyka Jordan; Frances Dooley; Kathryn H Bowles; Ruth M Masterson Creber
Journal:  J Palliat Med       Date:  2018-08-21       Impact factor: 2.947

8.  Systematic vs. on-demand early palliative care in gastric cancer patients: a randomized clinical trial assessing patient and healthcare service outcomes.

Authors:  Emanuela Scarpi; Monia Dall'Agata; Vittorina Zagonel; Teresa Gamucci; Raffaella Bertè; Elisabetta Sansoni; Elena Amaducci; Chiara Maria Broglia; Sara Alquati; Ferdinando Garetto; Stefania Schiavon; Silvia Quadrini; Elena Orlandi; Andrea Casadei Gardini; Silvia Ruscelli; Daris Ferrari; Maria Simona Pino; Roberto Bortolussi; Federica Negri; Silvia Stragliotto; Filomena Narducci; Martina Valgiusti; Alberto Farolfi; Oriana Nanni; Romina Rossi; Marco Maltoni
Journal:  Support Care Cancer       Date:  2018-10-24       Impact factor: 3.603

9.  To Treat or Not to Treat Metastatic Cancer Patients with Poor Performance Status: a Prospective Experience.

Authors:  Tamás Kullmann; Hélène Gauthier; Camille Serrate; Damien Pouessel; Christine le Maignan; Jean-Louis Misset; Stéphane Culine
Journal:  Pathol Oncol Res       Date:  2016-09-07       Impact factor: 3.201

10.  Phase angle for prognostication of survival in patients with advanced cancer: preliminary findings.

Authors:  David Hui; Swati Bansal; Margarita Morgado; Rony Dev; Gary Chisholm; Eduardo Bruera
Journal:  Cancer       Date:  2014-06-04       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.